Pfizer vaccine for children may be available in November
The drugmaker and its partner, Germany's BioNTech, say they expect to request U.S. emergency use authorization of their vaccine in children ages 5 to 11 'in the coming weeks.' |!|…
The drugmaker and its partner, Germany's BioNTech, say they expect to request U.S. emergency use authorization of their vaccine in children ages 5 to 11 'in the coming weeks.' |!|…